首页> 外国专利> Salt related abexinostato novel Crystal form, Preparation method thereof and Pharmaceutical compositions containing it

Salt related abexinostato novel Crystal form, Preparation method thereof and Pharmaceutical compositions containing it

机译:盐相关的abesinostato新型晶型,其制备方法和含有该晶型的药物组合物

摘要

Abexinostato tosylate refers to the formula (ii), and the l form of this Crystal is characterized by the Powder diffraction pattern of the same X, the Raman Spectrum of this, and the CP / mas 13C NMR Spectra in Solid State.The Crystal Form I of abexinostato tosylate is intended for Cancer Treatment, more particularly for the treatment of carcinoma, a tumor, Neoplasm, Lymphoma, melanoma, glioma, a sarcoma or blastoma. This Crystalline form is especially valuable in an industrial context in view of its low hygroscopicity
机译:甲苯磺酸阿美吡浓酯(Abexinostato tosylate)是指式(ii),该晶体的l形由相同X的粉末衍射图,其拉曼光谱和固态的CP / mas 13C NMR光谱表征。甲苯磺酸阿贝毒素的I型用于癌症治疗,更特别地用于癌症,肿瘤,肿瘤,淋巴瘤,黑素瘤,神经胶质瘤,肉瘤或母细胞瘤的治疗。鉴于其低吸湿性,这种结晶形式在工业环境中特别有价值

著录项

  • 公开/公告号PE15912015A1

    专利类型

  • 公开/公告日2015-11-06

    原文格式PDF

  • 申请/专利权人 PHARMACYCLICS LLC;

    申请/专利号PE20150001875

  • 发明设计人 LETELLIER PHILIPPE;PIMONT-GARRO ANNE;

    申请日2014-03-03

  • 分类号C07D307/85;A61K31/343;A61P29/00;A61P35/00;

  • 国家 PE

  • 入库时间 2022-08-21 15:13:34

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号